Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-04-25

Clinical Trial Update: Point of Care HbA1c as a Screening Test for Type 2 Diabetes in First Nations [NA]

View source ↗

Summary

A clinical trial update evaluating point-of-care HbA1c as a screening test for Type 2 diabetes mellitus in First Nations populations, sponsored by the Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of British Columbia | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN